| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/24/2007 | US7208178 For facilitating the delivery of active agents, such as insulin, to a target |
| 04/24/2007 | US7208170 Powder teat dip germicide, fungicide and skin conditioner |
| 04/24/2007 | US7208155 Agent for treating allergic or hypersensitivity condition |
| 04/24/2007 | US7208146 Vaccine comprising at least two recombinant variable regions of immunoglobulin molecules derived from B-cell lymphoma cells, wherein cells express at least two different immunoglobulin molecules differing by one idiotype |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2167171C A method of protecting against neuron loss |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007043784A1 Rna aptamers and the uses thereof |
| 04/19/2007 | WO2007043641A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043589A1 Animal model of schizophrenia |
| 04/19/2007 | WO2007043542A1 Antituberculous composition comprising oxazole compounds |
| 04/19/2007 | WO2007043538A1 Composition for oral administration |
| 04/19/2007 | WO2007043365A1 Therapeutic agent for neurogenic pain |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007042851A1 Optimizing malignant disease-free survival by combined modality treatment |
| 04/19/2007 | WO2007016153A3 Tilmicosin formulation |
| 04/19/2007 | WO2006138668A3 Methods for treating dermatitis using mutant human il-4 compositions |
| 04/19/2007 | WO2006129859A3 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 04/19/2007 | WO2006055869A3 Antibiotic compounds, compositions and medical uses |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070088017 Benzothiazole derivatives for the treatment of diabetes |
| 04/19/2007 | US20070088000 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070087390 Opiate, cannabinoid, and estrogen receptors |
| 04/19/2007 | US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087037 Stimulation of cpt-1 as a means to reduce weight |
| 04/19/2007 | US20070087028 Intraluminal devices for the prevention and treatment of vascular disease |
| 04/19/2007 | US20070087015 Multivalent dengue virus vaccine |
| 04/19/2007 | US20070087009 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | CA2625773A1 Inhibition of interleukin-6 (il-6) receptor promotes pancreatic islet transplantation |
| 04/19/2007 | CA2624497A1 Antituberculosis drug combination comprising oxazole compounds |
| 04/19/2007 | CA2609116A1 Animal model of schizophrenia |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1774972A1 Use of selenium compounds, especially selenium yeasts in the treatment of Alzheimer, neurodegenerative diseases and diabetes |
| 04/18/2007 | EP1774028A1 Methods and compositions for treating obesity |
| 04/18/2007 | EP1773450A2 Therapeutically combinations |
| 04/18/2007 | EP1773403A2 Viral adjuvants |
| 04/18/2007 | EP1773397A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 04/18/2007 | EP1773396A1 Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| 04/18/2007 | EP1773395A2 A method for managing cholesterol with a serum-free and mitogen free cytokine mixture |
| 04/18/2007 | EP1773368A2 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 04/18/2007 | EP1773341A1 Piperazine derivatives for the treatment of female sexual disorders |
| 04/18/2007 | EP1773340A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 04/18/2007 | EP1773331A1 Imidazole and thiazole derivatives as antiviral agents |
| 04/18/2007 | EP1773325A1 Methods of using albuterol and calcium activated potassium channel openers |
| 04/18/2007 | EP1773318A1 Combination anticancer therapy and pharmaceutical compositions therefor |
| 04/18/2007 | EP1773314A2 Use of l-carnitine for the treatment of cardiovascular diseases |
| 04/18/2007 | EP1773304A2 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 04/18/2007 | EP1699468B1 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
| 04/18/2007 | EP1556061B1 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/18/2007 | EP1480636B1 Self emulsifying drug delivery systems for taxoids |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1429817B1 Porous ceramic composite bone grafts |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1392313B1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1313508B1 Combination containing an antifolate and methylmalonic acid lowering agent |
| 04/18/2007 | EP1307746B1 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP1017390B1 Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP1002071B1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950109A Compositions comprising cells and magnetic materials for targeted delivery |
| 04/18/2007 | CN1950108A Axon regeneration promoter |
| 04/18/2007 | CN1950097A Compressed pharmaceutical compositions comprising peg and electrolytes |
| 04/18/2007 | CN1948313A Preparation method of tiemoazoleamine-8-carboxylic acid water soluble derivative, anticancer activity and application in preparing anticancer medicine |
| 04/18/2007 | CN1947794A Medicine composition contg. sulfonylurea compounds and phenoxy acid type compounds |
| 04/18/2007 | CN1947793A Application of Entamoeba histolytica for treating malignant noumenal tumor |
| 04/18/2007 | CN1947708A Time selecting released prepn. contg. angiotensin II 1 receptor antagonist |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310644C Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 04/18/2007 | CN1310643C Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 04/17/2007 | USRE39573 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 04/17/2007 | US7205413 Comprises formamide solvent; for treatment of HIV/inhibiting proteases; crystal structure; kits |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205383 Peptide ligands of leukocyte integrins |
| 04/17/2007 | US7205343 Stabilized bioactive preparations and method of use |
| 04/17/2007 | US7205333 Therapy for influenza virus; inhaler |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205322 Thiazolidine compounds as calcium sensing receptor modulators |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |